Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 4, 2011, Pages 927-934

  Baroody, Fuad M ^a   Brown, David ^a   Gavanescu, Laura ^a   Detineo, Marcy ^a   Naclerio, Robert M ^a,b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Allergic rhinitis; clinical trial; fluticasone furoate; oxymetazoline; perennial; rhinitis medicamentosa

Indexed keywords

FLUTICASONE FUROATE; OXYMETAZOLINE; PLACEBO;

ADULT; ARTICLE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; EVENING DOSAGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERENNIAL RHINITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINOMETRY; TREATMENT DURATION;

ADMINISTRATION, INTRANASAL; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; NASAL DECONGESTANTS; OXYMETAZOLINE; RHINITIS, ALLERGIC, PERENNIAL;

EID: 79953670246     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.01.037     Document Type: Article

References (33)

1. J. Bousquet, H.J. Schünemann, T. Zuberbier, C. Bachert, C.E. Baena-Cagnani, P.J. Bousquet in collaboration with the WHO Collaborating Center of Asthma and Rhinitis (Montpellier) Development and implementation of guidelines in allergic rhinitis: an ARIA-GA2LEN paper Allergy 65 2010 1212 1221
2. P.H. Ratner, F. Hampel, J. Van Bavel, N.J. Amar, P. Daftary, and W. Wheeler Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis Ann Allergy Asthma Immunol 100 2008 74 81
3. G.J. Molderings, H. Bonisch, M. Bruss, J. Likungu, and M. Gothert Species-specific pharmacological properties of human alpha (2A)-adrenoreceptors Hypertension 36 2000 405 410
4. L. Bickford, S. Shakib, and D. Taverner The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled study Br J Clin Pharmacol 48 1999 53 56 (Pubitemid 29296663)
5. R.F. Lockey Rhinitis medicamentosa and the stuffy nose J Allergy Clin Immunol 118 2006 1017 1018 (Pubitemid 44666973)
6. B.J. Ferguson, S. Paramaesvaran, and E. Rubinstein A study of the effect of nasal steroid sprays in perennial allergic rhinitis patients with rhinitis medicamentosa Otolaryngol Head Neck Surg 125 2001 253 260 (Pubitemid 33662676)
7. E.F. Juniper, and G.H. Guyatt Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 21 1991 77 83
8. E. Beck-Speier, B. Oswald, K.L. Maier, E. Karg, and R. Ramseger Oxymetazoline inhibits and resolves inflammatory reactions in human neutrophils J Pharmacol Sci 110 2009 276 284
9. S. Koelsch, M. Tschaikin, and F. Sacher Anti-rhinovirus-specific activity of the alpha-sympathomimetic oxymetazoline Arzneimittelforschung 57 2007 475 482 (Pubitemid 47234863)
10. S. Sudsakorn, L. Kaplan, and D.A. Williams Simultaneous determination of triamcinolone acetonide and oxymetazoline hydrochloride in nasal spray formulations by HPLC J Pharm Biomed Anal 40 2006 1273 1280 (Pubitemid 43247471)
11. I. Beck-Speier, N. Dayal, E. Karg, K.L. Maier, G. Schumann, and M. Semmler Oxymetazoline inhibits proinflammatory reactions: effect on arachidonic acid-derived metabolites J Pharmacol Exp Ther 316 2006 843 851 (Pubitemid 43131014)
12. G.J. Westerveld, H.P. Voss, R.M. van der Hee, G.J. de Haan-Koelwijn, G.J. den Hartog, and R.A. Scheeren Inhibition of nitric oxide synthase by nasal decongestants Eur Respir J 16 2000 437 444
13. M.R. Corboz, M.A. Rivelli, G.G. Mingo, R.L. McLeod, L. Varty, and Y. Jia Mechanisms of decongestant activity of alpha 2-adrenoceptor agonists Pulm Pharmacol Ther 21 2008 449 454 (Pubitemid 351625928)
14. C.Y. Lin, P.H. Cheng, and S.Y. Fang Mucosal changes in rhinitis medicamentosa Ann Otol Rhinol Laryngol 113 2004 147 151
15. P. Graf, H. Hallen, and J.E. Juto Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers Clin Exp Allergy 25 1995 395 400
16. P. Graf, J. Enerdal, and H. Hallen Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis Arch Otolaryngol Head Neck Surg 125 1999 1128 1132 (Pubitemid 29473377)
17. P. Graf Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa Comment in: Clin Ther 22 2000 893 895
18. P. Graf, and H. Hallen One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment ORL J Otorhinolaryngol Relat Spec 59 1997 39 44 (Pubitemid 27129948)
19. P.M. Graf, and H. Hallen One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal Am J Rhinol 11 1997 67 72 (Pubitemid 27145634)
20. P. Graf Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity Rhinology 34 1996 9 13 (Pubitemid 26155374)
21. P. Graf, H. Hallen, and J.E. Juto Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers Clin Exp Allergy 25 1995 395 400
22. P. Graf, J. Enerdal, and H. Hallen Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis Arch Otolaryngol Head Neck Surg 125 1999 1128 1132 (Pubitemid 29473377)
23. B. Petruson Treatment with xylometazoline (Otrivin) nosedrops over a six-week period Rhinology 19 1981 167 172 (Pubitemid 11057696)
24. J.K. Yoo, H. Seikaly, and K.H. Calhoun Extended use of topical nasal decongestants Comment in: Laryngoscope 108 1998 1255
25. H. Watanabe, T.H. Foo, B. Djazaeri, P. Duncombe, I.S. Mackay, and S.R. Durham Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebounds congestion or tachyphylaxis Rhinology 41 2003 167 174 (Pubitemid 37254098)
26. L. Zhang, D. Han, X. Song, K. Wang, and H. Wang Effect of oxymetazoline on healthy human nasal ciliary beat frequency measured with high-speed digital microscopy and mucociliary transport time Ann Otol Rhinol Laryngol 117 2008 127 133 (Pubitemid 351287916)
27. M. Talaat, A. Belal, T. Aziz, M. Mandour, and A. Maher Rhinitis medicamentosa: electron microscopic study J Laryngol Otol 95 1981 125 131 (Pubitemid 11180495)
28. A. Tas, R. Yagiz, O. Yalcin, C. Uzun, G. Huseyinova, and M.K. Adali Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study Otolaryngol Head Neck Surg 132 2005 608 612 (Pubitemid 40460893)
29. P.M. Graf, and H. Hallen Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nasal spray ORL J Otorhinolaryngol Relat Spec 60 1998 334 338 (Pubitemid 28464324)
30. S. Elwany, and S. Abdel-Salaam Treatment of rhinitis medicamentosa with fluticasone propionate-an experimental study Eur Arch Otorhinolaryngol 258 2001 116 119 (Pubitemid 32260928)
31. S. Vaidyanathan, P. Williamson, K. Cleaie, F. Khan, and B. Lipworth Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion Am J Respir Crit Care Med 182 2010 19 24
32. B.Q. Lanier, E.O. Meltzer, D. Gates, T. Shekar, and A. Teper Onset and duration of action of concomitant administration of mometasone furoate nasal spray with oxymetazoline nasal spray versus either drug alone and placebo in subjects with seasonal allergic rhinitis J Allergy Clin Immunol 125 2010 AB173
33. G. Gross, E.O. Meltzer, D. Gates, T. Shekar, and A. Teper Impact of concomitant administration of mometasone furoate and oxymetazoline nasal sprays vs either drug alone or placebo on quality of life in subjects with seasonal allergic rhinitis J Allergy Clin Immunol 125 2010 AB174